Platform

Imagine a world in which you can input your age, lifestyle, and genetic information into an app and obtain personalized recommendations about the food you should eat or avoid and behaviors you should modify to help maintain your health.

At the Stanford Center for Genomics and Personalized Medicine (SCGPM), we are applying our expertise on the science and ethics of genomics to build a new collaborative model of science focused on transforming the practice of medicine. This creates a new paradigm of patient-centered medicine that can monitor the entire genome of individuals to vastly improve disease prediction, prevention, and treatment of conditions such as cancer, diabetes, heart disease, asthma, schizophrenia, and many others.

SCGPM is one of nine biomedical platforms at Stanford that build strengths in fundamental research and translate these discoveries to add specificity and precision to the diagnosis and treatment of diseases in ways that improve patient care and outcomes.

Stanford is uniquely positioned to drive such an endeavor. We have extraordinary talent in science, engineering and medicine; our location in Silicon Valley provides unique opportunities for technological collaborations; our faculty are highly successful at obtaining competitive funding for their research; and we are leaders in the ethics of personalized medicine and in training physicians to help patients understand their genetic information.

Genomics, in particular, requires technologically advanced facilities, and computational infrastructure and benefits from an economy of scale that can only be achieved in center settings like the SCGPM. Our Center offers an omics driven biomedical platform composed of state-of-the-art laboratory and computational facilities to an interdisciplinary research community.